ArticleBMC medical informatics and decision making2026
Explainable machine learning model for identifying key risk factors in congenital heart disease prediction using questionnaire data: a retrospective case-control study.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundCurrent neonatal congenital heart disease (CHD) screening strategies face significant challenges in low-income or underdeveloped regions due to a shortage of experienced physicians. Therefore, we aim to develop a cost-effective method to identify high-risk populations, supplementing neonatal screening.
methodsA multicenter case-control study was conducted in three hospitals in Zhejiang, China, from September 2022 to July 2024. Pregnant women were surveyed using a self-designed questionnaire, and newborns were diagnosed using echocardiography. We utilized three steps to establish a prediction model for neonatal CHD. Initially, LASSO regression was used to screen variables. Subsequently, five representative machine learning (ML) algorithms, including SVM, XGBoost, Random Forest (RF), Logistic Regression (LR) and LightGBM, were applied to establish the CHD risk prediction models. Finally, the Shapley Additive exPlanation (SHAP) method and logistic regression were adopted to identify key risk factors for CHD.
resultsA total of 1,633 mother-infant pairs were included, with 437 infants diagnosed with CHD. Among the five machine learning models, XGBoost showed the best performance, with an AUC of 0.724 on the internal test set and 0.706 on the external validation cohort. The internal AUCs for RF, SVM, LightGBM, and LR were 0.673, 0.647, 0.672, and 0.649, respectively. The key risk factors for CHD were identified as COVID-19 infection within the three months prior to the last menstrual period, gestational medication use and viral infections during pregnancy. The odds ratios (ORs) with 95% confidence intervals (CIs) were 8.31 (4.86-14.72), 2.24 (1.65-3.03), 1.49 (1.13-1.97), respectively.
conclusionsOur CHD prediction model is non-invasive, cost-effective, and demonstrates robust performance, making it a valuable supplement to routine neonatal screening for identifying newborns at high risk of CHD. The ML model may contribute to guiding better clinical risk assessment and decision making for neonatal CHD. CLINICAL
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.